i24news: New technology could revolutionize market of 500 million diabetes patients

CEO Nadav Kidron speaks with i24 News about the potential of oral insulin.

Read and Watch here.  

You may also be interested

Insulin pill co Oramed jumps on Nasdaq listing plans
Linkedin-in Facebook-f Twitter Youtube

Copyright © 2022 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy

Join our mailing list

Linkedin-in Facebook-f Twitter Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Annual shareholder meeting
Investor Relations
SEC filings
Investor FAQ
Governance documents
Investor tools
Oravax Medical
Skip to content